Dr. Pennina Safer
General Partner
Pennina joined Medica in 2002, bringing extensive biotech industry experience and relationships from both the U.S. and Israel. Prior
to joining Medica, Pennina was at Concord Ventures, where she supported the fund’s entry into biotechnology investing. Upon moving to
Israel in 1998, she took on the role of VP R&D at CBD Technologies, now a wholly owned subsidiary of FuturaGene PLC (LSE:FGN),
a world leader in agricultural biotechnology. Pennina spent 14 years at Genetics Institute, one of the early Boston based biotech
companies, which was ultimately acquired in 1996 by American Home Products for $1B. Pennina roles within GI ranged from Staff Scientist
to Director of Research Technology Acquisitions. She played a key role in new business evaluation and corporate acquisitions.
Pennina received her PhD in Human Genetics from Yale University, and did a post-doctoral fellowship at the Roche
Institute of Molecular Biology.
Back to Team
